Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
1.
Eur Rev Med Pharmacol Sci ; 22(9): 2588-2597, 2018 05.
Article in English | MEDLINE | ID: mdl-29771442

ABSTRACT

OBJECTIVE: The aim of this study was to investigate the role of microRNA-222 (miR-222) in osteosarcoma (OS), and to further explore the potential molecular mechanism. PATIENTS AND METHODS: We measured the level of miR-222 in OS tissues and cell lines using quantitative Real-time polymerase chain reaction. Synthesized miR-222 mimics or inhibitors were obtained to up-regulate or down-regulate the expression of miR-222 in U2OS or Saos2 cells. Cell counting kit-8 (CCK8) and colony formation assay were employed to detect the ability of cell proliferation, and transwell assay was used to confirm the ability of cell invasion. Furthermore, luciferase assay and Western blot were applied to verify the target of miR-222 in OS. RESULTS: The level of miR-222 in OS tumor tissue samples was significantly lower than that in normal group. Over-expression of miR-222 decreased cell proliferation and invasion in U2OS cells while knockdown of miR-222 promoted cell growth and metastasis in Saos2 cells. Furthermore, YWHAG was found to be a candidate target of miR-222 using several databases. Elevated level of miR-222 inhibited YWHAG expression while reduced miR-222 promoted YWHAG expression. Also, up-regulation of YWHAG restored the inhibiting effect of miR-222 mimics. CONCLUSIONS: We identified for the first time that the expression level of miR-222 was reduced in OS tissues as well as in OS cell lines. miR-222 could inhibit cell proliferation and invasion via down-regulating YWHAG. These data could provide a potential target for the biological treatment of OS.


Subject(s)
14-3-3 Proteins/metabolism , Bone Neoplasms/metabolism , Cell Movement , Cell Proliferation , MicroRNAs/metabolism , Osteosarcoma/metabolism , 14-3-3 Proteins/genetics , 3' Untranslated Regions , Binding Sites , Bone Neoplasms/genetics , Bone Neoplasms/pathology , Cell Line, Tumor , Gene Expression Regulation, Neoplastic , Humans , MicroRNAs/genetics , Neoplasm Invasiveness , Osteosarcoma/genetics , Osteosarcoma/secondary , Signal Transduction
2.
CPT Pharmacometrics Syst Pharmacol ; 6(6): 401-408, 2017 06.
Article in English | MEDLINE | ID: mdl-28544534

ABSTRACT

Polatuzumab vedotin, an antibody-drug conjugate containing monomethyl auristatin E, was associated with an incidence of grade ≥2 peripheral neuropathy (PN) of 55-72% in patients with indolent non-Hodgkin lymphoma in a phase II study, when dosed 1.8-2.4 mg/kg every 3 weeks until progression or for a maximum of 17 cycles. To quantify the correlation of conjugate exposure and treatment duration with PN risk, a time-to-event model was developed using data from phase I and II studies. The model suggested that PN risk increased with conjugate exposure and treatment cycles, and a trend for increased risk with body weight and albumin concentration. When capping the treatment duration to six to eight cycles, the risk ratio of a dose of 2.4 mg/kg vs. 1.8 mg/kg was ≥1.29; the predicted incidence of grade ≥2 PN at 1.8-2.4 mg/kg dose levels was 17.8-37.2%, which is comparable with other antimicrotubule agents for lymphoma treatment.


Subject(s)
Antibodies, Monoclonal/adverse effects , Antineoplastic Agents/adverse effects , Immunoconjugates/adverse effects , Models, Biological , Peripheral Nervous System Diseases/chemically induced , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/therapeutic use , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Humans , Immunoconjugates/administration & dosage , Immunoconjugates/therapeutic use , Lymphoma, Non-Hodgkin/blood , Lymphoma, Non-Hodgkin/drug therapy , Peripheral Nervous System Diseases/blood , Rituximab/administration & dosage , Rituximab/therapeutic use , Serum Albumin/analysis
3.
CPT Pharmacometrics Syst Pharmacol ; 5(12): 665-673, 2016 12.
Article in English | MEDLINE | ID: mdl-27863168

ABSTRACT

An integrated pharmacokinetics (PK) model that simultaneously describes concentrations of total antibody (Tab) and antibody-conjugated monomethyl auristatin E (acMMAE) following administration of monomethyl auristatin E (MMAE)-containing antibody-drug conjugates (ADCs) was developed based on phase I PK data with extensive sampling for two ADCs. Two linear two-compartment models that shared all parameters were used to describe the PK of Tab and acMMAE, except that the deconjugation rate was an additional clearance pathway included in the acMMAE PK model compared to Tab. Further, the model demonstrated its ability to predict Tab concentrations and PK parameters based on observed acMMAE PK and various reduced or eliminated Tab PK sampling schemes of phase II data. Thus, this integrated model allows for the reduction of Tab PK sampling in late-phase clinical development without compromising Tab PK characterization.


Subject(s)
Immunoconjugates/pharmacokinetics , Lymphoma, Non-Hodgkin/drug therapy , Oligopeptides/pharmacokinetics , Computer Simulation , Drug Dosage Calculations , Humans , Immunoconjugates/administration & dosage , Models, Biological , Models, Theoretical , Oligopeptides/administration & dosage , Pharmaceutical Preparations
4.
Leukemia ; 29(7): 1578-86, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25708834

ABSTRACT

Antibody drug conjugates (ADCs), in which cytotoxic drugs are linked to antibodies targeting antigens on tumor cells, represent promising novel agents for the treatment of malignant lymphomas. Pinatuzumab vedotin is an anti-CD22 ADC and polatuzumab vedotin an anti-CD79B ADC that are both linked to the microtubule-disrupting agent monomethyl auristatin E (MMAE). In the present study, we analyzed the activity of these agents in different molecular subtypes of diffuse large B-cell lymphoma (DLBCL) both in vitro and in early clinical trials. Both anti-CD22-MMAE and anti-CD79B-MMAE were highly active and induced cell death in the vast majority of activated B-cell-like (ABC) and germinal center B-cell-like (GCB) DLBCL cell lines. Similarly, both agents induced cytotoxicity in models with and without mutations in the signaling molecule CD79B. In line with these observations, relapsed and refractory DLBCL patients of both subtypes responded to these agents. Importantly, a strong correlation between CD22 and CD79B expression in vitro and in vivo was not detectable, indicating that patients should not be excluded from anti-CD22-MMAE or anti-CD79B-MMAE treatment because of low target expression. In summary, these studies suggest that pinatuzumab vedotin and polatuzumab vedotin are active agents for the treatment of patients with different subtypes of DLBCL.


Subject(s)
Antibodies, Monoclonal/pharmacology , CD79 Antigens/immunology , Immunoconjugates/pharmacology , Lymphoma, Large B-Cell, Diffuse/drug therapy , Lymphoma, Large B-Cell, Diffuse/immunology , Sialic Acid Binding Ig-like Lectin 2/immunology , Apoptosis/drug effects , Blotting, Western , CD79 Antigens/genetics , Cell Cycle/drug effects , Cell Proliferation/drug effects , Clinical Trials, Phase I as Topic , Cohort Studies , Flow Cytometry , Follow-Up Studies , Humans , Immunoenzyme Techniques , Lymphoma, Large B-Cell, Diffuse/classification , Lymphoma, Large B-Cell, Diffuse/pathology , Mutation/genetics , Neoplasm Staging , Prognosis , Sialic Acid Binding Ig-like Lectin 2/genetics , Tumor Cells, Cultured
5.
Cell Death Dis ; 5: e1059, 2014 Feb 13.
Article in English | MEDLINE | ID: mdl-24525735

ABSTRACT

Inhibition of protein neddylation, particularly cullin neddylation, has emerged as a promising anticancer strategy, as evidenced by the antitumor activity in preclinical studies of the Nedd8-activating enzyme (NAE) inhibitor MLN4924. This small molecule can block the protein neddylation pathway and is now in clinical trials. We and others have previously shown that the antitumor activity of MLN4924 is mediated by its ability to induce apoptosis, autophagy and senescence in a cell context-dependent manner. However, whether MLN4924 has any effect on tumor angiogenesis remains unexplored. Here we report that MLN4924 inhibits angiogenesis in various in vitro and in vivo models, leading to the suppression of tumor growth and metastasis in highly malignant pancreatic cancer, indicating that blockage of angiogenesis is yet another mechanism contributing to its antitumor activity. At the molecular level, MLN4924 inhibits Cullin-RING E3 ligases (CRLs) by cullin deneddylation, causing accumulation of RhoA at an early stage to impair angiogenic activity of vascular endothelial cells and subsequently DNA damage response, cell cycle arrest and apoptosis due to accumulation of other tumor-suppressive substrates of CRLs. Furthermore, we showed that inactivation of CRLs, via small interfering RNA (siRNA) silencing of its essential subunit ROC1/RBX1, recapitulates the antiangiogenic effect of MLN4924. Taken together, our study demonstrates a previously unrecognized role of neddylation in the regulation of tumor angiogenesis using both pharmaceutical and genetic approaches, and provides proof of concept evidence for future development of neddylation inhibitors (such as MLN4924) as a novel class of antiangiogenic agents.


Subject(s)
Angiogenesis Inhibitors/pharmacology , Chorioallantoic Membrane/blood supply , Cyclopentanes/pharmacology , Endothelial Cells/drug effects , Neovascularization, Pathologic , Neovascularization, Physiologic/drug effects , Pancreatic Neoplasms/blood supply , Pancreatic Neoplasms/drug therapy , Pyrimidines/pharmacology , Ubiquitin-Activating Enzymes/antagonists & inhibitors , Animals , Apoptosis/drug effects , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Cycle Checkpoints/drug effects , Cell Line, Tumor , Chick Embryo , Cullin Proteins/metabolism , DNA Damage , Dose-Response Relationship, Drug , Endothelial Cells/enzymology , Endothelial Cells/pathology , Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/enzymology , Humans , Male , Mice , Mice, Inbred C57BL , Mice, Nude , NEDD8 Protein , Pancreatic Neoplasms/pathology , Protein Processing, Post-Translational , RNA Interference , Rats , Rats, Sprague-Dawley , Time Factors , Tissue Culture Techniques , Transfection , Tumor Burden/drug effects , Ubiquitin-Activating Enzymes/metabolism , Ubiquitins/metabolism , Xenograft Model Antitumor Assays , rhoA GTP-Binding Protein/genetics , rhoA GTP-Binding Protein/metabolism
6.
Scand J Immunol ; 73(4): 301-8, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21223350

ABSTRACT

Paclitaxel (PTX) is one of the most widely used clinical antitumour drugs in chemotherapy nowadays. Its effect on immune system has become a hot spot of research in recent years. Here, we demonstrated that PTX not only decreased the percentage of CD4+Foxp3+ regulatory T (Treg) cells both in vitro and in vivo but also impaired cell viability and cytokine production of Treg cells rather than CD4+Foxp3- effector T (Teff) cells. As PTX has been reported to mimic the activity of LPS to trigger the toll-like receptor 4 (TLR4) signalling pathway in macrophages, we investigated the possible role of TLR4 in the effect of PTX. However, although TLR4 expression on Treg cells was higher than that on Teff cells, the expression level remained unaltered in both Treg and Teff cells after PTX treatment. Surface molecules and activation markers in Treg and Teff cells did not change, either. Further study showed that the effect of PTX on TLR4-/- mice deficient in TLR4 signalling was similar to that on C57BL/6 mice both in vivo and in vitro. These data indicate that the selective impairment of Treg cells by PTX is independent of TLR4.


Subject(s)
Forkhead Transcription Factors/metabolism , Paclitaxel/pharmacology , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/pathology , Toll-Like Receptor 4/metabolism , Animals , Carcinoma, Lewis Lung/drug therapy , Carcinoma, Lewis Lung/immunology , Cell Count , Cell Survival/drug effects , Cytokines/metabolism , Female , Mice , Mice, Inbred C57BL , Mice, Knockout , Paclitaxel/therapeutic use , Spleen/drug effects , Spleen/immunology , Spleen/pathology , T-Lymphocytes, Helper-Inducer/drug effects , T-Lymphocytes, Helper-Inducer/metabolism , T-Lymphocytes, Helper-Inducer/pathology , T-Lymphocytes, Regulatory/metabolism , Toll-Like Receptor 4/genetics
7.
J Clin Microbiol ; 46(8): 2766-73, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18579720

ABSTRACT

The pandemic spread of Vibrio parahaemolyticus is an international public health issue. Because of the outbreak potential of the organism, it is critical to establish an internationally recognized molecular subtyping protocol for V. parahaemolyticus that is both rapid and robust as a means to monitor its further spread and to guide control measures in combination with epidemiologic data. Here we describe the results of a multicenter, multicountry validation of a new PulseNet International standardized V. parahaemolyticus pulsed-field gel electrophoresis (PFGE) protocol. The results are from a composite analysis of 36 well-characterized V. parahaemolyticus isolates from six participating laboratories, and the isolates represent predominant serotypes and various genotypes isolated from different geographic regions and time periods. The discriminatory power is very high, as 34 out of 36 sporadic V. parahaemolyticus strains tested fell into 34 distinguishable PFGE groups when the data obtained with two restriction enzymes (SfiI and NotI) were combined. PFGE was further able to cluster members of known pandemic serogroups. The study also identified quality measures which may affect the performance of the protocol. Nonadherence to the recommended procedure may lead to high background in the PFGE gel patterns, partial digestion, and poor fragment resolution. When these quality measures were implemented, the PulseNet V. parahaemolyticus protocol was found to be both robust and reproducible among the collaborating laboratories.


Subject(s)
Bacterial Typing Techniques/standards , DNA, Bacterial/genetics , Electrophoresis, Gel, Pulsed-Field/standards , Molecular Epidemiology/standards , Vibrio parahaemolyticus/classification , Vibrio parahaemolyticus/genetics , Bacterial Typing Techniques/methods , Cluster Analysis , Deoxyribonucleases, Type II Site-Specific/metabolism , Genotype , Humans , Molecular Epidemiology/methods
8.
Oncogene ; 27(15): 2137-47, 2008 Apr 03.
Article in English | MEDLINE | ID: mdl-17952116

ABSTRACT

Metastasis and invasion occur in the majority of epithelial ovarian carcinoma at diagnosis. To delineate the molecular signature in ovarian cancer invasion, we established and characterized a human ovarian endometrioid carcinoma (EC) cell line OVTW59-P0 and its invasion-related sublines (P1-P4, in the order of increasing invasive activity). P4 showed faster migration and larger xenograft formation with metastasis than P0. By microarray analysis of different gene expression among P0-P4 sublines, one group of gene was found negatively correlated with cancer invasion. Among these genes, IGFBP-3 was identified as one of the most remarkably suppressed gene that showed lower gene expression in P4 than P0. Re-expression of IGFBP-3 in P4 effectively inhibited cell migration, invasion and metastasis, but did not affect cell proliferation. In 35 patients with EC tumors, low IGFBP-3 expression correlated clinically with higher tumor grade, advanced stage and poor survival. Our results provide evidence and indicate that IGFBP-3 plays an important role as an invasion-metastasis suppressor in ovarian EC.


Subject(s)
Carcinoma, Endometrioid/genetics , Genes, Tumor Suppressor , Insulin-Like Growth Factor Binding Protein 3/physiology , Ovarian Neoplasms/genetics , Adult , Aged , Carcinoma, Endometrioid/diagnosis , Carcinoma, Endometrioid/mortality , Cell Culture Techniques , Cell Line, Tumor , Cell Movement/genetics , Cluster Analysis , Cytogenetic Analysis , Disease Progression , Female , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Humans , Insulin-Like Growth Factor Binding Protein 3/genetics , Middle Aged , Neoplasm Invasiveness , Neoplasm Metastasis , Oligonucleotide Array Sequence Analysis , Ovarian Neoplasms/diagnosis , Ovarian Neoplasms/mortality , Prognosis , Survival Analysis
9.
Rheumatology (Oxford) ; 46(12): 1796-803, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18032537

ABSTRACT

OBJECTIVES: Systemic lupus erythematosus (SLE) is characterized by serological presence of anti-double-stranded DNA (dsDNA) antibodies and its pathogenesis remains unclarified. Our previous work found that syngeneic activated lymphocyte-derived DNA (ALD-DNA) induced SLE-like autoimmune disease in the SLE-non-prone BALB/c mice. Here, the biological and chemical characteristics of the somatic DNA were focused upon to investigate their contribution to the autoimmunity induction to provide clues for the understanding of the pathogenesis of SLE in non-susceptible strains. METHODS: Induction of anti-dsDNA antibodies, glomerulonephritis and proteinuria was evaluated in BALB/c mice after subcutaneous immunization with apoptotic DNA (annexin-V+) extracted from concanavalin A or UV-treated apoptotic splenocytes or necrotic DNA from necrotic splenocytes. The hypomethylated apoptotic DNA and the normal DNA were then methylated and demethylated, respectively, by CpG methylase or 5-azacytidine treatment to re-evaluate their immunogenicity in BALB/c mice. RESULTS: It was apoptotic but not necrotic DNA that induced SLE-like autoimmune disease and the level of apoptotic DNA was associated with the level of anti-dsDNA antibodies. The apoptotic DNA exhibited significantly lower methylation levels than the normal DNA. Methylation of the hypomethylated apoptotic DNA significantly impaired its ability to induce anti-dsDNA antibodies and proteinuria, while demethylation of the normal or necrotic DNA endowed them with the immunogenicity to induce the SLE-like syndrome. CONCLUSIONS: Our study provides direct evidence showing that DNA hypomethylation is essential for apoptotic DNA to induce SLE-like autoimmune disease in non-susceptible mice, which may help in elucidating the pathogenesis of SLE.


Subject(s)
Antibodies, Antinuclear/immunology , Apoptosis/immunology , DNA Methylation , Lupus Erythematosus, Systemic/immunology , Lupus Nephritis/immunology , Animals , Antibodies, Antinuclear/biosynthesis , Autoimmune Diseases/immunology , Autoimmune Diseases/physiopathology , DNA/immunology , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Female , Lupus Erythematosus, Systemic/physiopathology , Lupus Nephritis/physiopathology , Mice , Mice, Inbred BALB C , Probability , Sensitivity and Specificity , Statistics, Nonparametric
11.
Rheumatology (Oxford) ; 44(9): 1108-14, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15840592

ABSTRACT

OBJECTIVES: Systemic lupus erythematosus (SLE) is the prototype of autoimmune disease and the mechanisms underlying the disease have not yet been elucidated. Thus, animal models of SLE would facilitate investigation of pathogenetic mechanisms involved in the development of the disease. This study characterizes a murine model of SLE-like syndrome induced by syngeneic activated lymphocyte-derived DNA (referred to as ALD DNA). METHODS: Normal BALB/c mice were immunized subcutaneously with highly purified ALD DNA. Anti-double-stranded DNA (anti-dsDNA) antibodies were determined by enzyme-linked immunosorbent assay. Other SLE-associated autoantibodies were examined by indirect immunofluorescence and anti-ENA (extractable nuclear antigen) profile assay. Pathological changes were analysed by light microscopy and electron microscopy. Kidney cryostat sections were viewed by immunofluorescence for the presence of glomerular IgG and C3 deposits. Proteinuria was measured by Coomassie brilliant blue assay. RESULTS: High levels of anti-dsDNA antibodies and other autoantibodies frequently appearing in SLE were detectable in the sera of ALD DNA-immunized mice. Glomerulonephritis and glomerular deposition of IgG plus C3 were observed in the kidney sections. Moreover, proteinuria was seen in the immunized mice. CONCLUSIONS: SLE-like syndrome can be induced by ALD DNA in normal mice. This induced model may be useful for elucidating the mechanisms involved in autoimmunity to DNA and the development of SLE.


Subject(s)
DNA/immunology , Disease Models, Animal , Lupus Erythematosus, Systemic/etiology , Lymphocyte Activation/immunology , Animals , Antibodies, Antinuclear/biosynthesis , Autoimmunity , Complement C3/analysis , Female , Immunization , Immunoglobulin G/biosynthesis , Immunoglobulin Isotypes/biosynthesis , Lupus Erythematosus, Systemic/immunology , Lupus Nephritis/immunology , Lupus Nephritis/pathology , Mice , Mice, Inbred BALB C , Proteinuria/immunology
13.
J Clin Microbiol ; 40(5): 1621-5, 2002 May.
Article in English | MEDLINE | ID: mdl-11980931

ABSTRACT

We examined partial 18S ribosomal DNA (Rns) sequences of Acanthamoeba isolates cultured in a study of microbial keratitis in Hong Kong. Sequence differences were sufficient to distinguish closely related strains and were used to examine links between strains obtained from corneal scrape specimens, contact lenses, lens cases, lens case solutions, and home water-supply faucets of patients with Acanthamoeba. We also looked for evidence of mixed infections. Identification of Acanthamoeba Rns genotypes was based on sequences of approximately 113 bp within the genus-specific amplicon ASA.S1. This permitted genotype identification by using nonaxenic cultures. Of 13 specimens obtained from corneal scrapes, contact lenses, lens cases, or lens case solutions, 12 were Rns genotype T4 and the remaining one was Rns genotype T3. The sequences of corneal scrape specimens of two patients also were the same as those obtained from their contact lenses or lens case specimens. A possible triple-strain infection was indicated by three different T4 sequences in cultures from one patient's lenses. Although faucet water used by patients to clean their lenses is a possible source of infections, specimens isolated from the faucets at two Acanthamoeba keratitis patients' homes differed from their corneal scrape or lens specimens. The overall results demonstrate the potential of this Rns region for tracking Acanthamoeba keratitis strains in infections and for distinguishing single-strain and closely related multiple-strain infections even when other microorganisms might be present with the cultured specimens. They also confirm the predominance of Rns genotype T4 strains in Acanthamoeba keratitis infections.


Subject(s)
Acanthamoeba/isolation & purification , Contact Lenses/parasitology , Cornea/parasitology , DNA, Ribosomal/genetics , Keratitis/parasitology , RNA, Ribosomal, 18S/genetics , Water/parasitology , Acanthamoeba/classification , Acanthamoeba/genetics , Animals , Base Sequence , Genetic Variation , Genotype , Hong Kong , Humans , Molecular Sequence Data , Phylogeny , Water Supply
14.
Antimicrob Agents Chemother ; 45(3): 710-4, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11181348

ABSTRACT

Between 1994 and 1998, 97 imipenem-resistant Acinetobacter isolates were identified at the Prince of Wales Hospital, Hong Kong, China. A bla(IMP) PCR product was obtained from 23 of 35 viable cultures; 12 isolates belonged to genomic DNA group 3, 8 belonged to group 2 (Acinetobacter baumannii), 2 belonged to group 13TU, and 1 belonged to group 1. The bla(IMP) homologues were sequenced from two isolates from genomic DNA group 2 and one isolate each from groups 3 and 13TU. The four sequences included an identical 738-bp open reading frame, predicted to encode a polypeptide of 246 amino acids, with 95.6% homology to IMP-1 and 89.3% homology to IMP-2. The new enzyme, designated IMP-4, was partially purified. It had a pI of 8.0 and was strongly active against imipenem and meropenem, with V(max) values 53 and 8% of that for penicillin G, respectively. Strong activity was also seen against oxyimino-aminothiazolyl cephalosporins but not against aztreonam. Hydrolytic activity was inhibited by EDTA but not by clavulanate or tazobactam. Carbapenem MICs for most bla(IMP)-positive isolates were 4 to 32 microg/ml, but one isolate with the intact gene was susceptible, with imipenem and meropenem MICs of 0.25 and 0.5 microg/ml, respectively. The latter isolate did not produce the band with a pI of 8.0, and gene expression was inferred to have been lost. None of the isolates studied in detail contained extrachromosomal DNA, and carbapenem resistance was not transmissible to Escherichia coli. Nevertheless, the presence of bla(IMP-4) in different genomic DNA groups implies horizontal transfer, and sequences resembling a GTTRRRY integrase-dependent recombination motif were identified in the flanking regions of bla(IMP-4).


Subject(s)
Acinetobacter/genetics , Cross Infection/microbiology , beta-Lactamases/genetics , Acinetobacter/enzymology , Acinetobacter Infections/microbiology , Amino Acid Sequence , Escherichia coli , Hong Kong , Humans , Microbial Sensitivity Tests , Molecular Sequence Data , Plasmids/genetics , Sequence Homology, Amino Acid , Transformation, Bacterial , beta-Lactamases/metabolism
15.
J Clin Microbiol ; 39(1): 228-34, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11136776

ABSTRACT

In a previous study, we showed that Acinetobacter genomic DNA group 3 was the most common species among blood culture isolates and was commonly found on superficial carriage sites of the healthy and the sick, which are different findings from those reported in Europe and North America. We used amplified ribosomal DNA restriction analysis and pulsed-field gel electrophoresis to study further the molecular epidemiology of acinetobacters in our region. Over a study period of 6 weeks with 136 consecutive routine clinical isolates (1.33% of all specimens), genomic DNA groups 2 (Acinetobacter baumannii), 3, and 13TU were obtained from 59 of 69 positive patients. There is a significant difference in the specimen sources of the three genomic DNA groups, with group 13TU being significantly associated with the respiratory tract (chi-square exact test, P = 0.0064). Settle plates showed a significantly heavier environmental load from the intensive care unit (ICU) than from the four surgical wards examined (22 of 70 versus 76 of 120 plates with <5 colonies; chi-square test, P < 0. 0001). Genomic group 3 accounted for 6 of 12 clusters of possibly related strains among patients, between patients and the ICU environment, and in the ICU environment. Genomic groups 2 and 3 accounted for 21% of the 132 genomically identified isolates recovered from 21 of 41 local vegetables, 53 of 74 fish and meat samples, and 22 of 60 soil samples. Group 13TU was present only in patients' immediate surroundings. The role played by the environment and by human carriage should be evaluated in order to devise a cost-effective infection control program pertinent to our situation of acinetobacter endemicity.


Subject(s)
Acinetobacter Infections/epidemiology , Acinetobacter Infections/microbiology , Acinetobacter/classification , Acinetobacter/genetics , Infection Control , Acinetobacter/isolation & purification , Acinetobacter Infections/prevention & control , Cross Infection/epidemiology , Cross Infection/microbiology , Cross Infection/prevention & control , DNA, Bacterial/analysis , Electrophoresis, Gel, Pulsed-Field , Environmental Microbiology , Food Microbiology , Hong Kong , Hospital Units , Humans , Intensive Care Units , Molecular Epidemiology , Restriction Mapping/methods , Surgery Department, Hospital
17.
J Clin Microbiol ; 37(9): 2962-7, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10449482

ABSTRACT

We studied the carriage of Acinetobacter spp. at five superficial sites in 79 patients from two hospitals, in 133 healthy controls from the community (medical students and new nurses), and in 198 student nurses in different classes. A total of 431 isolates from 364 positive sites of 201 subjects and 124 blood culture isolates (1997 to 1998) were genospeciated by amplified ribosomal DNA restriction analysis. Genospecies 3 was the most common species. The carriage rate of student nurses (42 of 131) was significantly lower than that of new nurses from the community (25 of 38) (chi-square test, P = 0.0004; odds ratio [OR], 4.08; 95% confidence limits, 1.78 to 9.41) but not significantly different (P = 0.1) from that of patients in the same hospital (20 of 42). Genospecies from blood cultures and subjects (acute patients and student nurses) from Prince of Wales Hospital were similar to one another but different from subjects from the community or from another hospital (chi-square test, P < 0.0001). Half of the subjects who were positive at at least two sites had different genospecies. Of the 28 sites examined, 68% showed strain variation among isolates of the same genospecies by random amplified polymorphic DNA analysis. Half of the 106 subjects who had samples taken again within 6 weeks or 6 months later were positive only once. In the 17 subjects who were positive on at least two occasions, each occasion yielded different genospecies in 13 subjects. Our results indicate that skin carriage in the majority of healthy subjects is characterized by low density, variation in genospecies and strains, short-term duration, and the typicality of a given locality.


Subject(s)
Acinetobacter/isolation & purification , Skin/microbiology , Acinetobacter/classification , Acinetobacter/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Female , Genotype , Humans , Male , Middle Aged , Mucous Membrane/microbiology , Random Amplified Polymorphic DNA Technique , Seasons
18.
Cytometry ; 36(4): 333-9, 1999 Aug 01.
Article in English | MEDLINE | ID: mdl-10404149

ABSTRACT

BACKGROUND: The measurement of DNA content with propidium iodide (PI) in cells transfected with expression vectors encoding the green fluorescent protein (GFP) is a useful tool in studying a variety of biological functions of proteins within cells. The purpose of this study was to determine conditions of formaldehyde fixation that permit intracellular GFP fluorescence and adequate DNA histograms to be generated following transient transfection of cells with a GFP-encoding plasmid. Cell cycle analysis was also performed in GFP-positive cells. METHODS: The murine myeloid leukemic cell line, 32Dcl3, was used as the model system. Cells were transfected with a GFP-encoding plasmid (pEGFPC1). Following fixation in different formaldehyde concentrations and permeabilization with 70% ethanol, cells were stained with PI and analyzed by flow cytometry for GFP fluorescence and DNA content. Transfected cells were also analyzed for GFP fluorescence and DNA content following release from nocodazole block. RESULTS: Fixing cells in 0.51-1.75% formaldehyde concentrations prior to ethanol permeabilization resulted in 14-19% of transfected cells being GFP-positive, with acceptable coefficients of variation on the G(1) peak of DNA histograms. Analysis of cells synchronized to and released from the G(2)-M phase by nocodazole suggested that GFP-positive cells, when compared to GFP-negative cells, did not appear to progress out of G(2)-M following release from nocodazole block. Simultaneous detection of GFP fluorescence and DNA content by PI staining is possible following transient transfection of cells with a single expression vector encoding GFP. Our results demonstrate that GFP expression can be detected, using flow cytometry to perform cell cycle analysis in murine leukemic cells.


Subject(s)
DNA/analysis , Flow Cytometry/methods , Luminescent Proteins/analysis , Animals , Cell Cycle/drug effects , Gene Expression Regulation , Green Fluorescent Proteins , Leukemia, Myeloid , Luminescent Proteins/genetics , Mice , Microscopy, Fluorescence , Nocodazole/pharmacology , Propidium , Transfection , Tumor Cells, Cultured
20.
Genomics ; 51(3): 313-24, 1998 Aug 01.
Article in English | MEDLINE | ID: mdl-9721201

ABSTRACT

A high-density cDNA microarray with colorimetry detection system to simultaneously monitor the expression of many genes on nylon membrane is described and characterized. To quantify the expression of genes and to isolate differentially expressed genes, the southern hybridization process on filter membranes was employed. The levels of gene expression were represented by color intensities generated by colorimetric reactions in place of hazardous radioisotopes or costly laser-induced fluorescence detection. The gene expression patterns on nylon membranes were digitized by devices such as an economical flatbed scanner or a digital camera. The quantitative information of gene expression was retrieved by image analysis software. Quantitative comparison of the northern dot-blotting method with the microarray system is described. Applications employing single-color detection as well as dual-color detection to isolate differentially expressed genes among thousands of genes are demonstrated.


Subject(s)
DNA, Complementary/metabolism , DNA/analysis , Gene Expression/genetics , Blotting, Northern , Colorimetry/methods , DNA Probes/genetics , Doxorubicin/pharmacology , Genes, Plant/genetics , Genes, Tumor Suppressor/genetics , Humans , Image Processing, Computer-Assisted , Leukocytes/metabolism , Membranes, Artificial , Nucleic Acid Hybridization , Oncogenes/genetics , RNA, Messenger/genetics , Regression Analysis , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...